Literature DB >> 7948745

Soluble interleukin 6 receptor in biological fluids from human origin.

J T Frieling1, R W Sauerwein, J Wijdenes, T Hendriks, C J van der Linden.   

Abstract

OBJECTIVE: measurement of baseline soluble interleukin 6 receptor (sIL-6R) and interleukin 6 (IL-6) levels in biological fluids in non-pathological conditions. SUBJECTS AND MATERIALS: Blood and urine were obtained from healthy volunteers. Cerebrospinal fluid (CSF) and synovial fluid (SF) were obtained from patients during spinal puncture and athroscopy, respectively. Only CSF and SF of patients with proven non-pathological conditions were used in this study. Both sIL-6R and IL-6 were measured using ELISAs. It was shown that neither did sIL-6R interfere with the IL-6 ELISA nor did IL-6 interfere in the sIL-6R ELISA. Moreover, addition of recombinant sIL-6R to the IL-6 bio-assay (B9) did not influence IL-6 recovery.
RESULTS: using our sIL-6R ELISA we found baseline levels for sIL-6R in serum of 76.6 +/- 19.3 ng/ml in serum and 3.7 +/- 1.3 ng/ml in urine. In non-pathological conditions sIL-6R concentrations in CSF are 1.6 +/- 0.4 ng/ml, and in SF 11.6 +/- 3.3 ng/ml, while IL-6 concentrations are below detectable ranges in these fluids.
CONCLUSIONS: sIL-6R levels are detectable in serum, urine, CSF and SF during non-pathological conditions. sIL-6R levels in serum outrange levels in CSF, urine and SF and large interindividual differences in baseline concentrations for sIL-6R exist.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7948745     DOI: 10.1016/1043-4666(94)90061-2

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  8 in total

1.  Mechanism of interleukin-1- and tumor necrosis factor alpha-dependent regulation of the alpha 1-antichymotrypsin gene in human astrocytes.

Authors:  T Kordula; M Bugno; R E Rydel; J Travis
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

2.  Interleukin 6 is autoregulated by transcriptional mechanisms in cultures of rat osteoblastic cells.

Authors:  N Franchimont; S Rydziel; E Canalis
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

3.  Construction and characterization of a replication-deficient adenovirus expressing rat-soluble interleukin-6 receptor.

Authors:  V Thibault; B Terlain; F L Graham; J Gauldie
Journal:  Mol Med       Date:  1997-08       Impact factor: 6.354

Review 4.  Interleukin-6: structure-function relationships.

Authors:  R J Simpson; A Hammacher; D K Smith; J M Matthews; L D Ward
Journal:  Protein Sci       Date:  1997-05       Impact factor: 6.725

5.  Differential induction of pro- and anti-inflammatory cytokines in whole blood by bacteria: effects of antibiotic treatment.

Authors:  J T Frieling; J A Mulder; T Hendriks; J H Curfs; C J van der Linden; R W Sauerwein
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

6.  Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor.

Authors:  N J Van Wagoner; J W Oh; P Repovic; E N Benveniste
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

7.  IL-6 pathway-driven investigation of response to IL-6 receptor inhibition in rheumatoid arthritis.

Authors:  Jianmei Wang; Adam Platt; Ruchi Upmanyu; Søren Germer; Guiyuan Lei; Christina Rabe; Ryma Benayed; Andrew Kenwright; Andrew Hemmings; Mitchell Martin; Olivier Harari
Journal:  BMJ Open       Date:  2013-08-19       Impact factor: 2.692

Review 8.  Emerging roles for the IL-6 family of cytokines in pancreatic cancer.

Authors:  Gemma van Duijneveldt; Michael D W Griffin; Tracy L Putoczki
Journal:  Clin Sci (Lond)       Date:  2020-08-28       Impact factor: 6.124

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.